Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Schizophrenia

Free Subscription 24.11.2025 1 Am J Med Genet B Neuropsychiatr Genet 1 Am J Psychiatry 2 Biol Psychiatry 2 Mol Psychiatry 3 Psychiatry Res 3 Psychol Med 8 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. CHEN P, Wang L, Wang F, Xu W, et al
   COMT rs4680 and DAOA rs947267 Polymorphism Interact to Influence Cognition and Psychiatric Symptoms in Chronic Schizophrenia.
   Am J Med Genet B Neuropsychiatr Genet. 2025 Nov 15. doi: 10.1002/ajmg.b.33067.
   PubMed         Abstract available
   
   

   
   Am J Psychiatry

2. KANTROWITZ JT, Mayer MR, Choo TH, Liu K, et al
   Effect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of Action.
   Am J Psychiatry. 2025 Nov 19:appiajp20250034. doi: 10.1176/appi.ajp.20250034.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

3. TURKOZER HB, Lizano P, Tamminga CA, Silverstein SM, et al
   Vision and Psychosis: A Clinical Translational Perspective.
   Biol Psychiatry. 2025 Nov 15:S0006-3223(25)01611.
   PubMed         Abstract available
   
   
4. VAN DER WALT K, Stein DJ, Zoghbi AW
   Genetic evidence for a neuro-immune model of schizophrenia.
   Biol Psychiatry. 2025 Nov 12:S0006-3223(25)01608.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

5. DEAKIN B, Liddle E, Rathnaiah M, Gregory CC, et al
   Investigating the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequences.
   Mol Psychiatry. 2025 Nov 19. doi: 10.1038/s41380-025-03337.
   PubMed         Abstract available
   
   
6. VELEZ-PEREZ E, Demirlek C, Zeng V, Silverstein S, et al
   Retinal cytoarchitectural alterations across the psychosis spectrum and their correlates with cognition: a UK biobank nested case-control study.
   Mol Psychiatry. 2025 Nov 15. doi: 10.1038/s41380-025-03343.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

7. SAKA IM, Arslan FC, Demir S, Mentese A, et al
   The relationship between serum Interleukin- 6, Interleukin- 18, Interleukin- 2, Eotaxin-1, Monocyte Chemoattractant Protein 1 levels and cognitive functions in treatment-resistant schizophrenia.
   Psychiatry Res. 2025;355:116835.
   PubMed         Abstract available
   
   
8. SUN A, Eakins RE, Gozlan EC, Chobrutskiy A, et al
   A quantitative assessment of TRB CDR3-CMV antigen chemical interactions distinguishes schizophrenia patients in case/control comparisons.
   Psychiatry Res. 2025;355:116834.
   PubMed         Abstract available
   
   
9. MIZUTANI R, Saiga R, Yamamoto Y, Inomoto C, et al
   Pyramidal soma size in the anterior cingulate cortex is small in schizophrenia and correlates with hallucination score.
   Psychiatry Res. 2025;355:116822.
   PubMed         Abstract available
   
   

   
   Psychol Med

10. MADSEN MK
    Comment on 'Dopamine D(2/3)R availability after discontinuation of antipsychotic treatment: a [(11)C]raclopride PET study in remitted first-episode psychosis patients' by de Beer et al. 2025.
    Psychol Med. 2025;55:e348.
    PubMed        
    
    
11. YU H, Wang W, Qiao M, Yang M, et al
    Network analysis of relationships among psychopathology, cognitive function, and psychosocial functioning in independent samples of Chinese with schizophrenia or bipolar disorder.
    Psychol Med. 2025;55:e353.
    PubMed         Abstract available
    
    
12. LI C, Tse W, Chu ST, Zhou H, et al
    Long-term mortality and associated factors in first episode psychosis: a 25-year follow-up study.
    Psychol Med. 2025;55:e355.
    PubMed         Abstract available
    
    

    
    Schizophr Res

13. DAS N, Dhamija R, Mistak D, Diaz LD, et al
    Epidemiological analysis of schizophrenia and incarceration: A multi-center exploration of the criminalization of mental illness in the United States.
    Schizophr Res. 2025;287:73-81.
    PubMed         Abstract available
    
    
14. SEIF P, Del Re EC, Tamminga CA, Pearlson GD, et al
    Does insight improve during the course of psychosis?
    Schizophr Res. 2025;287:63-70.
    PubMed         Abstract available
    
    
15. PARIS J, Laurendi O, Arnet V, Galletly C, et al
    Cannabis use and cardiometabolic risk in schizophrenia.
    Schizophr Res. 2025;287:54-62.
    PubMed         Abstract available
    
    
16. SERAFIM PHM, Gadelha A, Massuda R, Louza M, et al
    The challenges in measuring symptoms of schizophrenia: An exploratory graph analysis of the Positive and Negative Syndrome Scale (PANSS).
    Schizophr Res. 2025;287:46-53.
    PubMed         Abstract available
    
    
17. FAN YS, Ye M, Xu Y, Xu Y, et al
    Spatio-temporal information transition abnormalities across brain functional networks in early-onset schizophrenia.
    Schizophr Res. 2025;287:37-45.
    PubMed         Abstract available
    
    
18. CIAROLLA A, Bobilev AM, Dybowski F, Fang Y, et al
    The hippocampal-cortical system cerebral blood flow in schizophrenia: Primary disease versus antipsychotic medication effects.
    Schizophr Res. 2025;287:3-15.
    PubMed         Abstract available
    
    
19. ABDULLAH M, Lin SH, Huang LC, Yang YK, et al
    Assessing plasma and brain glutamate in treatment resistant and non-resistant schizophrenia: a peripheral-central disconnect.
    Schizophr Res. 2025;287:16-20.
    PubMed         Abstract available
    
    
20. DAZZAN P, Palaniyappan L
    TEMPORARY REMOVAL: Experiential Science in Schizophrenia Research: our new dedicated section.
    Schizophr Res. 2025 Nov 3:S0920-9964(25)00375.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.